Sugammadex Injection, Solution
Product Images NDC 0781-3469

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 0781-3469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure-1 (Sugammadex 01)

Chemical structure diagram of sugammadex, showing the molecular arrangement and bonding of the active ingredient sugammadex used in the injection solution by Sandoz Inc.*

FDA Label Image

Chemical- Structure-2 (Sugammadex 02)

Chemical structure of sugammadex, showing a cyclic arrangement of sugar and sulfide groups with multiple sodium carboxylate functional groups.*

FDA Label Image

Figure-1 (Sugammadex 03)

A line graph comparing the cumulative recovery rate over time (minutes) for sugammadex 2 mg/kg and neostigmine 0.05 mg/kg following rocuronium administration. The x-axis represents time to recovery in minutes up to 120, and the y-axis shows the cumulative recovery rate from 0 to 1. A legend and median recovery times are provided in the inset.*

FDA Label Image

Figure-2 (Sugammadex 04)

A Kaplan-Meier style plot showing cumulative recovery rate over time (minutes) comparing 2 mg/kg sugammadex versus 0.05 mg/kg neostigmine in patients receiving vecuronium. The plot shows sugammadex achieving faster and higher cumulative recovery rates. Median recovery times are 2.1 minutes for sugammadex and 29.0 minutes for neostigmine, with quartile ranges provided.*

FDA Label Image

200mg-carton (Sugammadex 05)

Sugammadex Injection 200 mg/2 mL sterile solution for intravenous use, packaged as 10 single-dose 2 mL vials. The label shows the product is for prescription use only, manufactured by Lek d.d., Slovenia for Sandoz Inc., with storage and dosage instructions included.*

FDA Label Image

500mg-carton (Sugammadex 06)

Sugammadex Injection 500 mg/5 mL (100 mg/mL) sterile solution for intravenous use in single-dose 5 mL vials. The carton contains 10 vials and is labeled by Sandoz Inc. The packaging includes dosage and storage instructions, manufacturer information, and cautionary notes about the solution and its use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.